CNMD · CONMED Corp · Documents

Oct 4

Current report 8-K

Financial results

Sep 30

Current report 8-K

Regulation FD disclosure

Sep 20

Current report 8-K Events of Sep 16

Director or officer change, or executive pay

Aug 14

Current report 8-K

Director or officer change, or executive pay

Aug 9

Current report 8-K

Other events

Aug 1

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $332.1M ▲ 4.5% Net income $29.98M ▲ 118.3% Diluted EPS $0.96 ▲ 123.3%

Jul 31

Earnings call

Q2 2024 earnings call

Jul 31

Current report 8-K

Financial results

May 28

Current report 8-K Events of May 22

Director or officer change, or executive pay

May 22

Current report 8-K

Shareholder vote results, Other events

Apr 25

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $312.27M ▲ 5.7% Net income $19.71M ▲ 983.5% Diluted EPS $0.63 ▲ 950.0%

Apr 24

Earnings call

Q1 2024 earnings call

Apr 24

Current report 8-K

Financial results

Apr 24

Current report 8-K Events of Apr 19

Director or officer change, or executive pay

Apr 8

Proxy statement DEF 14A Meeting May 22, 2024

Proxy statement

Apr 8

Annual report to holders ARS

Annual report to holders

Apr 8

Proxy statement DEFA14A

Proxy statement

Feb 28

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $1.24B ▲ 19.1% Net income $64.46M Diluted EPS $2.04

Feb 27

Current report 8-K Events of Feb 26

Other events

Jan 31

Earnings call

Q4 2023 earnings call

Jan 31

Current report 8-K

Financial results

Dec 5

Current report 8-K Events of Dec 4

Other events

Oct 26

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $304.58M ▲ 10.7% Net income $15.84M ▼ 65.7% Diluted EPS $0.50 ▼ 66.2%

Oct 25

Earnings call

Q3 2023 earnings call

Oct 25

Current report 8-K

Financial results

Aug 10

Current report 8-K

Other events

Jul 27

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $317.65M ▲ 14.6% Net income $13.73M Diluted EPS $0.43

Jul 26

Earnings call

Q2 2023 earnings call

Jul 26

Current report 8-K

Financial results

May 24

Current report 8-K

Shareholder vote results, Other events

Apr 27

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $295.47M ▲ 21.9% Net income $1.82M ▼ 87.9% Diluted EPS $0.06 ▼ 87.2%

Apr 26

Earnings call

Q1 2023 earnings call

Apr 26

Current report 8-K

Financial results

Apr 11

Proxy statement DEF 14A

Proxy statement

Apr 11

Annual report to holders ARS

Annual report to holders

Apr 11

Proxy statement DEFA14A

Proxy statement

Mar 30

Proxy statement PRE 14A

Proxy statement

Feb 27

Current report 8-K

Other events

Feb 21

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.05B ▲ 3.4% Net loss $80.58M Diluted EPS -$2.68

Feb 2

Earnings call

Q4 2022 earnings call

Feb 2

Current report 8-K

Financial results

Dec 27

Current report 8-K Events of Dec 20

Entered into a material agreement, New debt or off-balance-sheet obligation

Dec 7

Current report 8-K Events of Dec 6

Director or officer change, or executive pay

Dec 5

Current report 8-K

Other events

Nov 15

Current report 8-K

Regulation FD disclosure, Other events

Oct 27

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $275.09M ▲ 10.6% Net income $46.15M ▲ 208.7% Diluted EPS $1.48 ▲ 214.9%

Oct 26

Earnings call

Q3 2022 earnings call

Oct 26

Current report 8-K

Financial results

Aug 11

Current report 8-K

Other events

Aug 9

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure